Nomura Asset Management
BBH icon

Nomura Asset Management’s VanEck Biotech ETF BBH Stock Holding History

Nomura Asset Management’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,986
Closed -$1.76M – 925
2017
Q2 		$1.76M Hold
13,986
– – 0.02% 506
2017
Q1 		$1.67M Buy
13,986
+4,712
+51% +$551K 0.02% 525
2016
Q4 		$998K Hold
9,274
– – 0.02% 661
2016
Q3 		$1.07M Buy
+9,274
New +$1.06M 0.02% 620

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Nomura Asset Management's BBH Position: Q3 2017 in Review

Nomura Asset Management sold out of VanEck Biotech ETF (BBH) in Q3 2017, closing a stake of 13,986 shares — an estimated $1.76M sold.

Nomura Asset Management first reported a position in BBH in Q3 2016 and held it in 4 quarters. The position peaked at $1.76M in Q2 2017. 79 funds tracked by Wall St. Rank hold BBH as of Q3 2017.

  • Nomura Asset Management reported no remaining VanEck Biotech ETF position as of Q3 2017 after selling out during the quarter.
  • Nomura Asset Management sold 13,986 VanEck Biotech ETF shares in Q3 2017, an estimated $1.76M.
  • Nomura Asset Management first reported a position in VanEck Biotech ETF in Q3 2016 and held it in 4 quarters.
  • Nomura Asset Management's VanEck Biotech ETF position peaked at $1.76M in Q2 2017.
  • 79 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2017.

Based on Nomura Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.